Medifast (MED) Competitors $16.92 -0.22 (-1.28%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MED vs. HLF, USNA, NUS, NATR, VERU, EL, IPAR, PBH, FARM, and JVAShould you be buying Medifast stock or one of its competitors? The main competitors of Medifast include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Veru (VERU), Estée Lauder Companies (EL), Inter Parfums (IPAR), Prestige Consumer Healthcare (PBH), Farmer Bros. (FARM), and Coffee (JVA). Medifast vs. Herbalife USANA Health Sciences Nu Skin Enterprises Nature's Sunshine Products Veru Estée Lauder Companies Inter Parfums Prestige Consumer Healthcare Farmer Bros. Coffee Medifast (NYSE:MED) and Herbalife (NYSE:HLF) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment. Which has more risk and volatility, MED or HLF? Medifast has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Herbalife has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Which has higher valuation and earnings, MED or HLF? Herbalife has higher revenue and earnings than Medifast. Herbalife is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedifast$674.48M0.27$99.42M$0.6625.64Herbalife$5.00B0.13$142.20M$0.857.62 Does the media refer more to MED or HLF? In the previous week, Herbalife had 1 more articles in the media than Medifast. MarketBeat recorded 4 mentions for Herbalife and 3 mentions for Medifast. Herbalife's average media sentiment score of 0.37 beat Medifast's score of 0.02 indicating that Herbalife is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medifast 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Herbalife 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts rate MED or HLF? Medifast currently has a consensus price target of $17.00, suggesting a potential upside of 0.47%. Herbalife has a consensus price target of $9.90, suggesting a potential upside of 52.78%. Given Herbalife's stronger consensus rating and higher probable upside, analysts clearly believe Herbalife is more favorable than Medifast.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Herbalife 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Is MED or HLF a better dividend stock? Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 39.0%. Herbalife pays an annual dividend of $1.20 per share and has a dividend yield of 18.5%. Medifast pays out 1,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Herbalife pays out 141.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Does the MarketBeat Community believe in MED or HLF? Herbalife received 332 more outperform votes than Medifast when rated by MarketBeat users. Likewise, 67.26% of users gave Herbalife an outperform vote while only 63.62% of users gave Medifast an outperform vote. CompanyUnderperformOutperformMedifastOutperform Votes38363.62% Underperform Votes21936.38% HerbalifeOutperform Votes71567.26% Underperform Votes34832.74% Do insiders & institutionals hold more shares of MED or HLF? 95.5% of Medifast shares are owned by institutional investors. 2.5% of Medifast shares are owned by insiders. Comparatively, 0.9% of Herbalife shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is MED or HLF more profitable? Herbalife has a net margin of 1.73% compared to Medifast's net margin of 1.09%. Medifast's return on equity of 15.98% beat Herbalife's return on equity.Company Net Margins Return on Equity Return on Assets Medifast1.09% 15.98% 11.01% Herbalife 1.73%-18.66%7.12% SummaryHerbalife beats Medifast on 12 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Medifast News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MED vs. The Competition Export to ExcelMetricMedifastfood preparations & kindred products IndustryStaples SectorNYSE ExchangeMarket Cap$185.07M$3.12B$14.03B$19.19BDividend YieldN/A3.12%2.76%3.58%P/E Ratio25.648.8621.9641.22Price / Sales0.270.982.6117.58Price / Cash1.7712.2621.1421.28Price / Book0.911.825.855.32Net Income$99.42M$136.11M$572.90M$989.67M7 Day Performance-11.69%-6.44%-1.80%-3.45%1 Month Performance-7.54%-5.52%-3.00%-3.73%1 Year Performance-75.21%42.72%2.85%12.06% Medifast Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDMedifast1.5391 of 5 stars$16.92-1.3%$17.00+0.5%-74.7%$185.07M$674.48M25.64870HLFHerbalife4.6776 of 5 stars$7.23-3.3%$9.90+36.9%-56.6%$728.73M$5.00B8.669,200USNAUSANA Health Sciences2.7805 of 5 stars$36.57-0.2%$35.00-4.3%-35.6%$697.02M$921.01M12.951,800Analyst UpgradeNews CoverageNUSNu Skin Enterprises3.55 of 5 stars$7.34-2.0%$8.88+20.9%-65.8%$364.88M$1.78B-3.593,700Analyst ForecastAnalyst RevisionGap DownNATRNature's Sunshine Products3.7941 of 5 stars$15.64+0.2%$19.00+21.5%-14.4%$288.97M$445.10M17.55814VERUVeru1.9745 of 5 stars$0.74+2.4%$4.00+440.5%-3.5%$108.32M$14.09M-1.51189Earnings ReportAnalyst ForecastELEstée Lauder Companies4.8829 of 5 stars$79.50-0.7%$98.57+24.0%-48.2%$28.54B$15.61B142.9362,000Positive NewsIPARInter Parfums4.5438 of 5 stars$135.88-0.2%$159.75+17.6%-8.2%$4.35B$1.42B29.36530Analyst ForecastPBHPrestige Consumer Healthcare3.7947 of 5 stars$82.65+0.4%$85.25+3.1%+29.7%$4.08B$1.11B20.02540Analyst UpgradePositive NewsFARMFarmer Bros.4.1077 of 5 stars$1.87-1.3%$5.25+180.1%-41.3%$39.87M$344.27M-5.281,003Positive NewsJVACoffee1.2054 of 5 stars$4.17-2.8%N/A+306.7%$23.81M$76.11M21.4580Gap Down Related Companies and Tools Related Companies HLF Competitors USNA Competitors NUS Competitors NATR Competitors VERU Competitors EL Competitors IPAR Competitors PBH Competitors FARM Competitors JVA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:MED) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.